Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
58 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Farmaceutica from Leuven, company number BE0473789966, closed financial year 2025 with a result of € 2,544 after tax. For that financial year Farmaceutica recorded revenue of € 162,242 and equity of € 184,125. Compared with financial year 2024, the result moved from € 15,925 to € 2,544. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 12, 2026.
€ 184,125
▲ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 2,544
▼ 84% vs 2024
Profit after tax over the fiscal year.
€ 169,538
▲ 10% vs 2024
Cash and bank balances on the last day of the fiscal year.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,557
▲ € 1,542 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 278
▼ 93% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | € 145,476 | € 174,527 | € 162,242 | ▼ 7% |
| Gross margin | € 8,990 | € 11,812 | € 15,543 | € 14,355 | ▼ 8% |
| Profit after taxes | € 6,651 | € 11,734 | € 15,925 | € 2,544 | ▼ 84% |
| Equity | € 153,921 | € 165,655 | € 181,580 | € 184,125 | ▲ 1% |
| Total debts | € 2,181 | € 3,490 | € 3,820 | € 1,835 | ▼ 52% |
| Cash | € 146,143 | € 154,359 | € 153,956 | € 169,538 | ▲ 10% |
| Retained profit | € 91,622 | € 103,356 | € 119,282 | € 121,826 | ▲ 2% |
| Balance sheet total | € 156,102 | € 169,145 | € 185,400 | € 185,960 |
Key figures of Farmaceutica, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to Farmaceutica?
What happened at Farmaceutica in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 2,544 (▼ 84% vs 2024). Source: NBB ↗
- Start of the company according to the CBE. KBO
In short
From € 6,651 profit in 2022 to € 2,544 profit in 2025.
Paid € 1,429 in corporate taxes since 2022.
Best year ever: 2024, with € 15,925 profit.
A new publication or filing at Farmaceutica? We notify you, reason included.
Follow FarmaceuticaDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Farmaceutica are Sophie van der Ark, Camille Van der Eecken and Jesse Driesens.
Directors
According to the 2025 annual accounts
Sophie van der Ark
Penningmeester van het bestuursorgaan
Camille Van der Eecken
Vice-chairman of the board
Jesse Driesens
Chairman of the board
Establishments
Establishment units
Physical locations of this company
Herestraat 49 box 423
3000 Leuven
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 58 companies are registered at this address.
All companies at this address →The Association for European Paediatric and Congenital Cardiology
Stfran.
€ 75,987 revenue · 2023
ALFAGEN: Alumni van de FAculteit GENeeskunde KU Leuven
Rega Instituut
€ -7,459 gross margin · 2025
Vlaamse Vereniging voor Seksuologie
+53 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0473.789.966
- VAT number
- BE 0473.789.966
- Registered office
- Herestraat 49 bus 423, 3000 Leuven
- Names & denominations
- Farmaceutica
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 21 November 2000
- Peppol
- Active · Active since 16 Dec 2025
- Activities · NACE
Overige persoonlijke diensten